Nanotechnology research support at the national heart, lung, and blood institute

Circulation Research

Volumn 109, Issue 3, 2011, Pages 250-254

  Buxton, Denis B ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; ENDOTHELIAL CELL GROWTH FACTOR; NANOMATERIAL; NANOPARTICLE; SOMATOMEDIN; VASCULOTROPIN;

APOPTOSIS; ARTICLE; ATHEROSCLEROTIC PLAQUE; BIOSENSOR; BLOOD DISEASE; CELL REGENERATION; DRUG DELIVERY SYSTEM; HEALTH PROGRAM; HEART DISEASE; HEART INFARCTION; HUMAN; IN VITRO STUDY; LUNG DISEASE; LUNG INFECTION; MACROPHAGE FUNCTION; MICROFLUIDIC ANALYSIS; MITOCHONDRIAL PERMEABILITY; MOLECULAR IMAGING; NANOTECHNOLOGY; NATIONAL HEALTH ORGANIZATION; NONHUMAN; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PHOSPHORYLATION; POINT OF CARE TESTING; PRIORITY JOURNAL; REDUCTION KINETICS; STEM CELL TRANSPLANTATION; VASCULAR SMOOTH MUSCLE;

BIOMEDICAL RESEARCH; CARDIOVASCULAR DISEASES; HUMANS; NANOTECHNOLOGY; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE (U.S.); RESEARCH SUPPORT AS TOPIC; UNITED STATES;

EID: 79961087470     PISSN: 00097330     EISSN: 15244571     Source Type: Journal    
DOI: 10.1161/RES.0b013e31822a97cd     Document Type: Article

References (28)

1. Project on emerging nanotechnologies. http://www.nanotechproject.org/ inventories/consumer/analysis-draft/.
2. Buxton DB, Lee SC, Wickline SA, Ferrari M. Recommendations of the National Heart, Lung, and Blood Institute Nanotechnology Working Group. Circulation. 2003;108:2737-2742. (Pubitemid 37498973)
3. Bioengineering Nanotechnology Initiative (SBIR [R43/R44]). http://grants.nih.gov/grants/guide/pa-files/pa-10-150.html.
4. Bioengineering Nanotechnology Initiative (STTR [R41/R42]). http://grants.nih.gov/grants/guide/pa-files/PA-10-149.html.
5. Nanoscience and Nanotechnology in Biology and Medicine. (R01) http://grants. NIH. Gov/grants/guide/pa-files/pa-11-148.html.
6. Nanoscience and Nanotechnology in Biology and Medicine (R21). http://grants1. NIH. Gov/grants/guide/pa-files/pa-11-149.html.
7. Bioengineering Research Partnerships (BRP) [R01]. http://grants. NIH. Gov/grants/guide/pa-files/par-10-234.html.
8. Briley-Saebo KC, Cho YS, Shaw PX, Ryu SK, Mani V, Dickson S, Izadmehr E, Green S, Fayad ZA, Tsimikas S. Targeted iron oxide particles for in vivo magnetic resonance detection of atherosclerotic lesions with antibodies directed to oxidation-specific epitopes. J Am Coll Cardiol. 2011;57:337-347.
9. Morishige K, Kacher DF, Libby P, Josephson L, Ganz P, Weissleder R, Aikawa M. High-resolution magnetic resonance imaging enhanced with superparamagnetic nanoparticles measures macrophage burden in atherosclerosis. Circulation. 2010;122:1707-1715.
10. Lekas M, Lekas P, Latter DA, Kutryk MB, Stewart DJ. Growth factorinduced therapeutic neovascularization for ischaemic vascular disease: time for a re-evaluation? Curr Opin Cardiol. 2006;21:376-384. (Pubitemid 44315071)
11. Golub JS, Kim Y-T, Duvall CL, Bellamkonda RV, Gupta D, Lin AS, Weiss D, Robert Taylor W, Guldberg RE. Sustained VEGF delivery via PLGA nanoparticles promotes vascular growth. Am J Physiol Heart Circ Physiol. 2010;298:H1959-H1965.
12. Padin-Iruegas ME, Misao Y, Davis ME, Segers VFM, Esposito G, Tokunou T, Urbanek K, Hosoda T, Rota M, Anversa P, Leri A, Lee RT, Kajstura J. Cardiac progenitor cells and biotinylated insulin-like growth factor-1 nanofibers improve endogenous and exogenous myocardial regeneration after infarction. Circulation. 2009;120:876-887.
13. Haun JB, Yoon T-J, Lee H, Weissleder R. Magnetic nanoparticle biosensors. Wiley Interdisciplinary Revs Nanomed Nanobiotechnol. 2010;2:291-304.
14. Wildgruber M, Lee H, Chudnovskiy A, Yoon TJ, Etzrodt M, Pittet MJ, Nahrendorf M, Croce K, Libby P, Weissleder R, Swirski FK. Monocyte subset dynamics in human atherosclerosis can be profiled with magnetic nano-sensors. PLoS One. 2009;4:e5663.
15. Fraikin J-L, Teesalu T, McKenney CM, Ruoslahti E, Cleland AN. A high-throughput label-free nanoparticle analyser. Nat Nano. 2011;6:308-313.
16. Shaw SY, Westly EC, Pittet MJ, Subramanian A, Schreiber SL, Weissleder R. Perturbational profiling of nanomaterial biologic activity. Proc Natl Acad Sci USA. 2008;105:7387-7392. (Pubitemid 351830027)
17. Anderson BR, Bogomolovas J, Labeit S, Granzier H. The effects of PKCa phosphorylation on the extensibility of titin's PEVK element. J Struct Biol. 2010;170:270-277.
18. Qiu H, Zhu Y, Sun Z, Trzeciakowski JP, Gansner M, Depre C, Resuello RRG, Natividad FF, Hunter WC, Genin GM, Elson EL, Vatner DE, Meininger GA, Vatner SF. Short communication: vascular smooth muscle cell stiffness as a mechanism for increased aortic stiffness with aging. Circ Res. 2010;107:615-619.
19. Debold EP, Saber W, Cheema Y, Bookwalter CS, Trybus KM, Warshaw DM, VanBuren P. Human actin mutations associated with hypertrophic and dilated cardiomyopathies demonstrate distinct thin filament regulatory properties in vitro. J Mol Cell Cardiol. 2010;48:286-292.
20. New SEP, Aikawa E. Molecular imaging insights into early inflammatory stages of arterial and aortic valve calcification. Circ Res. 2011;108:1381-1391.
21. Nahrendorf M, Keliher E, Marinelli B, Leuschner F, Robbins CS, Gerszten RE, Pittet MJ, Swirski FK, Weissleder R. Detection of macrophages in aortic aneurysms by nanoparticle positron emission tomography-computed tomography. Arterioscler Thromb Vasc Biol. 2011;31:750-757.
22. Sadat U, Taviani V, Patterson AJ, Young VE, Graves MJ, Teng Z, Tang TY, Gillard JH. Ultrasmall superparamagnetic iron oxide-enhanced magnetic resonance imaging of abdominal aortic aneurysms-a feasibility study. Eur J Vasc Endovasc Surg. 2011;41:167-174.
23. Nchimi A, Defawe O, Brisbois D, Broussaud TKY, Defraigne J-O, Magotteaux P, Massart B, Serfaty J-M, Houard X, Michel J-B, Sakalihasan N. MR imaging of iron phagocytosis in intraluminal thrombi of abdominal aortic aneurysms in humans1. Radiology. 2010;254:973-981.
24. Swirski FK, Wildgruber M, Ueno T, Figueiredo J-L, Panizzi P, Iwamoto Y, Zhang E, Stone JR, Rodriguez E, Chen JW, Pittet MJ, Weissleder R, Nahrendorf M. Myeloperoxidase-rich Ly-6C+ myeloid cells infiltrate allografts and contribute to an imaging signature of organ rejection in mice. J Clin Invest. 2010;120:2627-2634.
25. Wu YL, Ye Q, Sato K, Foley LM, Hitchens TK, Ho C. Noninvasive evaluation of cardiac allograft rejection by cellular and functional cardiac magnetic resonance. J Am Coll Cardiol Cardiovasc Imaging. 2009;2:731-741.
26. Hashi CK, Glickman MH. Preclinical results of a prosthetic, early-stick graft with functional endothelium [epub ahead of print Nov. 20, 2010]. J Vasc Access. 2010.
27. de Mel A, Punshon G, Ramesh B, Sarkar S, Darbyshire A, Hamilton G, Seifalian AM. In situ endothelialization potential of a biofunctionalised nanocomposite biomaterial-based small diameter bypass graft. Biomed Mater Eng. 2009;19:317-331.
28. Scientific portfolio management. http://www. Discoverylogic. Com/portfolio/scientific-portfolio-management. Aspx.